JP2023518973A5 - - Google Patents

Info

Publication number
JP2023518973A5
JP2023518973A5 JP2022558084A JP2022558084A JP2023518973A5 JP 2023518973 A5 JP2023518973 A5 JP 2023518973A5 JP 2022558084 A JP2022558084 A JP 2022558084A JP 2022558084 A JP2022558084 A JP 2022558084A JP 2023518973 A5 JP2023518973 A5 JP 2023518973A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
salt
oligopeptide
substituted
acceptable acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022558084A
Other languages
English (en)
Japanese (ja)
Other versions
JP7667177B2 (ja
JP2023518973A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/024142 external-priority patent/WO2021195372A1/en
Publication of JP2023518973A publication Critical patent/JP2023518973A/ja
Publication of JP2023518973A5 publication Critical patent/JP2023518973A5/ja
Application granted granted Critical
Publication of JP7667177B2 publication Critical patent/JP7667177B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022558084A 2020-03-26 2021-03-25 抗炎症性および成長促進活性を有するデスアセチルグルコサミンムラミルジペプチドの親油性エナンチオマー Active JP7667177B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063000364P 2020-03-26 2020-03-26
US63/000,364 2020-03-26
PCT/US2021/024142 WO2021195372A1 (en) 2020-03-26 2021-03-25 Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity

Publications (3)

Publication Number Publication Date
JP2023518973A JP2023518973A (ja) 2023-05-09
JP2023518973A5 true JP2023518973A5 (enExample) 2025-02-07
JP7667177B2 JP7667177B2 (ja) 2025-04-22

Family

ID=77892334

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022558084A Active JP7667177B2 (ja) 2020-03-26 2021-03-25 抗炎症性および成長促進活性を有するデスアセチルグルコサミンムラミルジペプチドの親油性エナンチオマー

Country Status (13)

Country Link
US (1) US12492222B2 (enExample)
EP (1) EP4126040B1 (enExample)
JP (1) JP7667177B2 (enExample)
KR (1) KR102897673B1 (enExample)
CN (1) CN115605226A (enExample)
AU (1) AU2021241625B2 (enExample)
BR (1) BR112022019202A2 (enExample)
CA (1) CA3172936A1 (enExample)
ES (1) ES3014076T3 (enExample)
MX (1) MX2022011751A (enExample)
PL (1) PL4126040T3 (enExample)
WO (1) WO2021195372A1 (enExample)
ZA (1) ZA202210586B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3929293A3 (en) 2015-04-03 2022-03-16 University Of Massachusetts Fully stabilized asymmetric sirna
WO2017030973A1 (en) 2015-08-14 2017-02-23 University Of Massachusetts Bioactive conjugates for oligonucleotide delivery
WO2017132669A1 (en) 2016-01-31 2017-08-03 University Of Massachusetts Branched oligonucleotides
WO2018237245A1 (en) 2017-06-23 2018-12-27 University Of Massachusetts TWO TAIL SELF-ADMINISTRATION SIRNA AND ASSOCIATED METHODS
BR112021002440A2 (pt) 2018-08-10 2021-05-04 University Of Massachusetts oligonucleotídeos modificados visando snps
WO2020041769A1 (en) 2018-08-23 2020-02-27 University Of Massachusetts O-methyl rich fully stabilized oligonucleotides
CN113614232A (zh) 2019-01-18 2021-11-05 马萨诸塞大学 动态药代动力学修饰锚
EP3946369A4 (en) 2019-03-26 2023-10-18 University Of Massachusetts MODIFIED OLIGONUCLEOTIDES WITH INCREASED STABILITY
KR20220047989A (ko) 2019-08-09 2022-04-19 유니버시티 오브 매사추세츠 Snp를 표적화하는 화학적으로 변형된 올리고뉴클레오타이드
US12365894B2 (en) 2019-09-16 2025-07-22 University Of Massachusetts Branched lipid conjugates of siRNA for specific tissue delivery
AU2021244600A1 (en) 2020-03-26 2022-11-03 University Of Massachusetts Synthesis of modified oligonucleotides with increased stability
CN115605226A (zh) 2020-03-26 2023-01-13 纽特莱特公司(Us) 具有抗炎和生长促进活性的去乙酰基葡糖胺胞壁酰二肽的亲脂对映异构体
CA3174079A1 (en) 2020-05-26 2021-12-02 Anastasia Khvorova Synthetic oligonucleotides having regions of block and cluster modifications
WO2024102639A1 (en) * 2022-11-08 2024-05-16 The Scripps Research Institute N-arylpyrazole nod2 agonists as promoters of immune checkpoint inhibitor therapy

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
SI9011830B (sl) 1990-09-27 1999-12-31 Univerza V Ljubljani, Fakulteta Za Farmacijo Novi N-acildipeptidi, postopki za njihovo pripravo in farmacevtski pripravki, ki jih vsebujejo
JPH0655107B2 (ja) 1991-03-13 1994-07-27 全国農業協同組合連合会 家畜,家禽,および魚介類用の抗仮性狂犬病ならびに抗病性飼料および飼料用添加物
WO1993013791A1 (en) 1992-01-20 1993-07-22 Peptech (Uk) Limited Use of muramyl peptides for enhancing animal production
MX9301789A (es) 1992-04-03 1993-10-01 Iaf Biochem Int Nuevos oligopeptidos lipofilicos con actividad inmunomoduladora.
CN1162920A (zh) * 1994-09-21 1997-10-22 英国佩普技术有限公司 胞壁酰肽化合物的应用
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
GB9618673D0 (en) * 1996-09-06 1996-10-16 Peptech Uk Ltd The use of muramyl peptides
RU2375047C2 (ru) 2004-03-26 2009-12-10 Лек Фармасьютиклз Д.Д. Фармацевтическая лекарственная форма, устойчивая к действию желудочного сока, включающая n-(2-(2-фталимидоэтокси)ацетил)-l-аланил-d-глутаминовую кислоту (lk 423)
CA2666814A1 (en) 2006-08-21 2008-05-29 United Therapeutics Corporation Combination therapy for treatment of viral infections
WO2008070564A1 (en) 2006-12-01 2008-06-12 The Government Of The U.S.A, As Represented By The Secretary, Departmentof Health And Human Services Uses of muramyl dipeptide (mdp) for treating inflammation
KR20100059863A (ko) 2007-09-11 2010-06-04 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드 티모신 베타 4 단독 또는 세크로핀 a와의 배합물의 용도
CN101918001B (zh) 2007-12-06 2016-11-16 英特威国际有限公司 使用醋酸美仑孕酮和齐帕特罗或其盐的联合治疗
CN101756026A (zh) 2008-12-11 2010-06-30 天津瑞贝特科技发展有限公司 增强虾、蟹硬壳速度的营养组合物及其制备方法、应用
DE102009002044A1 (de) 2009-03-31 2010-10-07 Evonik Degussa Gmbh Dipeptide als Futtermitteladditive
BR112013027845A2 (pt) 2011-05-18 2017-01-03 Ajinomoto Kk Imunoestimulante, ração, método para produzir um imunoestimulante, e, método para imunoestimulação
CN102578414B (zh) 2012-02-23 2014-01-01 青岛绿曼生物工程有限公司 促进猪生长育肥、提高免疫力的复方蜂胶饲料添加剂及其制备方法
WO2013172517A1 (ko) 2012-05-16 2013-11-21 서울대학교산학협력단 뮤라밀-다이펩타이드를 포함하는 골소실 예방, 골재생 또는 골형성 촉진용 약학 조성물
EP2975046A1 (en) * 2014-07-16 2016-01-20 The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth Novel compounds
WO2017068149A1 (en) 2015-10-21 2017-04-27 Cysal Gmbh Aspartyl-dipeptides for aquaculture
EP3387005B1 (en) * 2015-12-10 2022-08-24 Bharat Biotech International Limited Novel muramyl peptide derivative compound, synthesis and uses thereof
CN109562158A (zh) 2016-06-23 2019-04-02 纽特莱特公司 在动物中促进生长和提高饲料转化率的方法
TWI634902B (zh) * 2017-10-28 2018-09-11 醫療財團法人徐元智先生醫藥基金會亞東紀念醫院 Use of glucosamine peptide compounds for the treatment of abnormal liver metabolism
WO2020019128A1 (zh) 2018-07-23 2020-01-30 深圳市健元医药科技有限公司 丙氨酸—赖氨酸—谷氨酸三肽衍生物及其应用
CN115605226A (zh) 2020-03-26 2023-01-13 纽特莱特公司(Us) 具有抗炎和生长促进活性的去乙酰基葡糖胺胞壁酰二肽的亲脂对映异构体

Similar Documents

Publication Publication Date Title
US20240033287A1 (en) Antimicrobial clay compositions and methods of using
ES2966909T3 (es) Compuestos y composiciones antimicrobianos, y usos de los mismos
ES2666909T3 (es) Composición que previene la enteritis necrótica en Galloanserae
JP2002514594A5 (enExample)
JP2011510045A (ja) 動物においてグラム陽性バクテリアにより引き起こされる感染症の予防及び処置の為のラクチレート
US12239616B2 (en) Food supplement and composition comprising choline butyrate salt and/or butyrylcholine
US20190191740A1 (en) Methods to Promote Growth and Improve Feed Conversion in Animals
US20220142204A1 (en) Clay compositions and methods for improving animal performance
JP5253168B2 (ja) 抗菌剤及びそれを含むヨーネ病治療剤
IE902378A1 (en) A bacterial preparation for use in poultry
EA031958B1 (ru) Состав, предотвращающий некротический энтерит у домашних птиц
CN104872399A (zh) 一种干扰素畜禽微生态添加剂
JP2011182748A (ja) 家畜又は家禽用飼料
US3958008A (en) Anthelmintic methods of use
US11738045B2 (en) Therapeutic clay compositions and methods of using
SK3222000A3 (en) The use of 8a-azalides in the treatment or prevention of bacterial respiratory and enteric infections in livestock animals
JP4814568B2 (ja) 免疫機能向上剤
JP2009511429A5 (enExample)
JP5758602B2 (ja) ホスホマイシンを有効成分とする魚類のエドワジエラ症治療剤
US3015606A (en) Dinitrobenzamide remedies for coccidiosis and salmonella infections
RU2415848C2 (ru) Способ усиления роста
NZ792610B2 (en) Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity
BE1024195B1 (nl) Voedingssupplement en farmaceutische samenstelling omvattende butyrylcholine
NZ792610A (en) Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity
WO2024181756A1 (ko) 영양분이 풍부한 미세조류인 스키조키트리움 속 균주를 활용한 연어양식용 배합사료 제조 방법